title: Systemic treatment approaches in her2-negative advanced breast cancer-guidance on the guidelines.
abstract: Despite advancements in the treatment of early-stage breast cancer, many patients still develop disease recurrence; others present with de novo metastatic disease. For most patients with advanced breast cancer, the primary treatment intent is noncurative-that is, palliative-in nature. The goals of treatment should therefore focus on maximizing symptom control and extending survival. Treatments should be evaluated on an individualized basis in terms of evidence, but also with full respect for the wishes of the patient in terms of acceptable toxicity. Given the availability of extensive reviews on the roles of endocrine therapy and her2 (human epidermal growth factor receptor 2)-targeted therapies for advanced disease, we focus here mainly on treatment guidelines for the non-endocrine management of her2-negative advanced breast cancer in a Canadian health care context.
authors.affiliation: Department of Oncology, Division of Medical Oncology, University of Alberta, Cross Cancer Institute, Edmonton, AB.
authors.forename: A A
authors.initials: AA
authors.lastname: Joy
authors.affiliation: Department of Oncology, Division of Medical Oncology, University of Alberta, Cross Cancer Institute, Edmonton, AB.
authors.forename: M
authors.initials: M
authors.lastname: Ghosh
authors.affiliation: Division of Medical Oncology, University of Ottawa and The Ottawa Hospital Research Institute, The Ottawa Hospital Cancer Centre, Ottawa, ON.
authors.forename: R
authors.initials: R
authors.lastname: Fernandes
authors.affiliation: Division of Medical Oncology, University of Ottawa and The Ottawa Hospital Research Institute, The Ottawa Hospital Cancer Centre, Ottawa, ON.
authors.forename: M J
authors.initials: MJ
authors.lastname: Clemons
keywords: Advanced breast cancer; biologic therapy; chemotherapy; endocrine-resistant breast cancer; her2-negativity; metastatic breast cancer; targeted therapy; treatment guidelines
references.citation: J Clin Oncol. 2010 Jul 10;28(20):3256-63
references.pmid: 20530276
references.citation: Clin Breast Cancer. 2009 Feb;9(1):29-33
references.pmid: 19299237
references.citation: Curr Oncol. 2012 Oct;19(5):e303-4
references.pmid: 23144577
references.citation: Breast Cancer Res Treat. 2014 Aug;146(3):567-72
references.pmid: 25001611
references.citation: PLoS One. 2014 Oct 17;9(10):e110469
references.pmid: 25329669
references.citation: Int J Nanomedicine. 2007;2(4):567-83
references.pmid: 18203425
references.citation: Breast. 2012 Jun;21(3):242-52
references.pmid: 22425534
references.citation: Oncologist. 2014 Feb;19(2):127-34
references.pmid: 24473225
references.citation: Clin Breast Cancer. 2015 Feb;15(1):8-15
references.pmid: 25218708
references.citation: Clin Cancer Res. 2013 Mar 1;19(5):1281-9
references.pmid: 23340303
references.citation: Breast. 2008 Jun;17(3):220-6
references.pmid: 18037292
references.citation: Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003372
references.pmid: 15846660
references.citation: Cancer. 2001 Oct 1;92(7):1759-68
references.pmid: 11745247
references.citation: Breast Cancer Res. 2013;15(5):R88
references.pmid: 24063698
references.citation: Oncologist. 2012;17(4):476-84
references.pmid: 22418569
references.citation: Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003366
references.pmid: 15846659
references.citation: Eur J Cancer. 2013 Jan;49(2):312-22
references.pmid: 22954665
references.citation: J Clin Oncol. 2007 Aug 10;25(23):3407-14
references.pmid: 17606974
references.citation: Clin Cancer Res. 1999 Jul;5(7):1696-702
references.pmid: 10430071
references.citation: J Natl Cancer Inst. 2014 Jan;106(1):djt337
references.pmid: 24317176
references.citation: Curr Med Res Opin. 2013 Feb;29(2):117-25
references.pmid: 23216340
references.citation: Eur J Cancer. 2012 Jan;48(1):1-11
references.pmid: 21741830
references.citation: Ann Oncol. 2014 Oct;25(10):1871-1888
references.pmid: 25234545
references.citation: Clin Breast Cancer. 2013 Dec;13(6):421-432.e8
references.pmid: 24267730
references.citation: Cochrane Database Syst Rev. 2013 Dec 18;(12):CD008792
references.pmid: 24347031
references.citation: J Clin Oncol. 2009 Apr 10;27(11):1753-60
references.pmid: 19273714
references.citation: Cancer. 2001 Nov 1;92(9):2267-72
references.pmid: 11745280
references.citation: Jpn J Clin Oncol. 2014 Jul;44(7):624-31
references.pmid: 24803548
references.citation: J Clin Oncol. 2003 Feb 15;21(4):588-92
references.pmid: 12586793
references.citation: CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29
references.pmid: 22237781
references.citation: J Clin Oncol. 2004 Jul 1;22(13):2587-93
references.pmid: 15226326
references.citation: J Geriatr Oncol. 2013 Oct;4(4):346-52
references.pmid: 24472478
references.citation: PLoS One. 2014 May 02;9(5):e96228
references.pmid: 24788655
references.citation: Curr Oncol. 2012 Dec;19(6):e414-21
references.pmid: 23300365
references.citation: J Clin Oncol. 2005 Nov 1;23(31):7794-803
references.pmid: 16172456
references.citation: Lancet Oncol. 2015 Jan;16(1):25-35
references.pmid: 25524798
references.citation: Clin Oncol (R Coll Radiol). 2012 Oct;24(8):e128-9
references.pmid: 22795828
references.citation: J Clin Oncol. 2014 Oct 10;32(29):3307-29
references.pmid: 25185096
references.citation: Ann Oncol. 2012 Oct;23 Suppl 7:vii11-9
references.pmid: 22997442
references.citation: J Clin Oncol. 2015 Jan 10;33(2):141-8
references.pmid: 25185099
references.citation: J Clin Oncol. 2013 May 10;31(14):1732-9
references.pmid: 23569309
references.citation: Nature. 2000 Aug 17;406(6797):747-52
references.pmid: 10963602
references.citation: Ann Oncol. 2014 Dec;25(12):2357-2362
references.pmid: 25231953
references.citation: Support Care Cancer. 2011 Mar;19(3):315-22
references.pmid: 21203780
references.citation: J Clin Oncol. 2014 Jul 1;32(19):2078-99
references.pmid: 24799465
references.citation: World J Clin Oncol. 2014 Dec 10;5(5):990-1001
references.pmid: 25493235
references.citation: Clin Oncol (R Coll Radiol). 1993;5(2):80-4
references.pmid: 8481365
references.citation: J Clin Oncol. 2000 Jul;18(14):2780-7
references.pmid: 10894879
references.citation: Cancer Chemother Pharmacol. 2013 Jun;71(6):1427-33
references.pmid: 23536163
references.citation: N Engl J Med. 2007 Dec 27;357(26):2666-76
references.pmid: 18160686
references.citation: Curr Oncol. 2012 Oct;19(5):259-68
references.pmid: 23144574
references.citation: Lancet Oncol. 2011 Sep;12(9):852-61
references.pmid: 21862407
references.citation: Nat Rev Clin Oncol. 2010 Feb;7(2):79-80
references.pmid: 20118978
references.citation: J Cancer. 2014 Mar 20;5(5):320-7
references.pmid: 24723974
references.citation: Breast. 2014 Oct;23(5):489-502
references.pmid: 25244983
references.citation: Breast Cancer Res Treat. 2013 Nov;142(1):101-7
references.pmid: 24129976
references.citation: Breast J. 2013 Mar-Apr;19(2):180-8
references.pmid: 23320984
references.citation: Curr Oncol. 2012 Apr;19(2):e75-83
references.pmid: 22514500
references.citation: Eur J Cancer. 2011 Nov;47(16):2387-95
references.pmid: 21757334
references.citation: Breast Cancer Res Treat. 2010 Nov;124(1):177-86
references.pmid: 20814815
references.citation: Eur J Cancer. 1994;30A(6):889
references.pmid: 7917555
references.citation: Curr Oncol. 2012 Apr;19(2):91-105
references.pmid: 22514495
references.citation: Clin Cancer Res. 2011 Sep 15;17(18):5858-66
references.pmid: 21813634
references.citation: J Clin Pharmacol. 2014 Oct;54(10):1134-43
references.pmid: 24771603
references.citation: N Engl J Med. 2010 Aug 19;363(8):733-42
references.pmid: 20818875
references.citation: J Clin Oncol. 2005 Sep 1;23(25):6260; author reply 6261
references.pmid: 16135495
references.citation: Breast Cancer Res Treat. 2013 Aug;141(1):111-7
references.pmid: 23942873
references.citation: J Clin Oncol. 2011 Jun 1;29(16):2144-9
references.pmid: 21464403
references.citation: Breast Cancer Res Treat. 2013 Jun;139(2):603-6
references.pmid: 23681402
references.citation: J Clin Oncol. 2010 Jul 10;28(20):3271-7
references.pmid: 20498394
references.citation: J Clin Oncol. 2010 Feb 10;28(5):723-30
references.pmid: 20026801
references.citation: Cancer Treat Rev. 2012 Oct;38(6):708-14
references.pmid: 22178456
references.citation: Ann Oncol. 2014 Apr;25(4):763-773
references.pmid: 24667713
references.citation: J Clin Oncol. 2008 Apr 20;26(12):1980-6
references.pmid: 18421049
references.citation: Breast Care (Basel). 2014 Feb;9(1):52-9
references.pmid: 24803888
references.citation: Semin Oncol Nurs. 2010 Aug;26(3):195-202
references.pmid: 20656143
references.citation: Pharmacoeconomics. 2015 Feb;33(2):137-48
references.pmid: 25213036
references.citation: Curr Med Res Opin. 2012 Dec;28(12):1911-9
references.pmid: 23145857
references.citation: Oncologist. 2011;16(9):1203-14
references.pmid: 21880861
references.citation: J Clin Oncol. 2012 Feb 20;30(6):587-92
references.pmid: 22124102
references.citation: Oncol Lett. 2013 Mar;5(3):983-991
references.pmid: 23426861
references.citation: Clin Breast Cancer. 2005 Dec;6(5):460-3
references.pmid: 16381631
references.citation: Breast Cancer Res Treat. 2010 Jul;122(2):409-18
references.pmid: 20454927
references.citation: N Engl J Med. 2012 Aug 2;367(5):435-44
references.pmid: 22853014
references.citation: Exp Ther Med. 2014 May;7(5):1420-1426
references.pmid: 24940450
references.citation: Curr Oncol. 2010 Aug;17(4):42-7
references.pmid: 20697513
references.citation: Clin Pharmacokinet. 2009;48(2):131-41
references.pmid: 19271785
references.citation: J Support Oncol. 2013 Mar;11(1):14-21
references.pmid: 22763232
references.citation: J Clin Oncol. 1998 Oct;16(10):3439-60
references.pmid: 9779724
references.citation: Breast Cancer Res Treat. 2010 Jun;121(2):261-71
references.pmid: 20229176
references.citation: Lancet. 2011 Mar 12;377(9769):914-23
references.pmid: 21376385
references.citation: Br J Cancer. 1998 Jun;77(12):2257-63
references.pmid: 9649142
references.citation: BMC Cancer. 2014 Mar 07;14:166
references.pmid: 24606768
references.citation: Nature. 2012 Apr 04;486(7403):395-9
references.pmid: 22495314
references.citation: J Clin Oncol. 2008 Oct 1;26(28):4672-8
references.pmid: 18824714
references.citation: J Bone Oncol. 2013 May 15;2(3):123-31
references.pmid: 26909282
references.citation: Lancet Oncol. 2007 Mar;8(3):219-25
references.pmid: 17329192
references.citation: Ann Oncol. 2014 Oct;25(10):2096
references.pmid: 25085505
references.citation: Clin Oncol (R Coll Radiol). 2012 Nov;24(9):593-603
references.pmid: 22748560
references.citation: J Clin Oncol. 2002 Jun 15;20(12):2812-23
references.pmid: 12065558
references.citation: J Clin Oncol. 2013 Jul 10;31(20):2586-92
references.pmid: 23733761
references.citation: Am J Clin Oncol. 2007 Jun;30(3):297-302
references.pmid: 17551309
references.citation: J Clin Oncol. 2012 Jun 1;30(16):1919-25
references.pmid: 22370325
references.citation: N Engl J Med. 2012 Feb 9;366(6):520-9
references.pmid: 22149876
references.citation: Breast Cancer Res Treat. 2014 Jul;146(1):153-62
references.pmid: 24924416
references.citation: Cancer. 2004 Aug 15;101(4):704-12
references.pmid: 15305399
references.citation: Ann Oncol. 2009 May;20(5):816-27
references.pmid: 19153118
references.citation: Breast Cancer Res Treat. 2014 Jan;143(1):141-51
references.pmid: 24292957
references.citation: CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29
references.pmid: 24399786
references.citation: J Clin Oncol. 2011 Apr 1;29(10):1252-60
references.pmid: 21383283
references.citation: Oncologist. 2007 Jul;12(7):785-97
references.pmid: 17673610
references.citation: Can J Cardiol. 2014 Aug;30(8):869-78
references.pmid: 25064580
references.citation: Support Care Cancer. 2014 Apr;22(4):863-4
references.pmid: 24474600
references.citation: Nat Rev Clin Oncol. 2013 Jul;10(7):377-89
references.pmid: 23712187
references.citation: Eur J Cancer Care (Engl). 2005 Jul;14(3):211-22
references.pmid: 15952965
references.citation: Nature. 2012 Apr 18;486(7403):346-52
references.pmid: 22522925
references.citation: J Clin Oncol. 1991 Dec;9(12):2148-52
references.pmid: 1960557
references.citation: Ann Oncol. 2002 May;13(5):797-801
references.pmid: 12075751
references.citation: Eur J Cancer. 1990 Jan;26(1):45-8
references.pmid: 2138477
references.citation: Curr Oncol. 2009 Sep;16(5):48-57
references.pmid: 19862361